HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maiko Morishita Selected Research

ASP3026

3/2021Safety and Antitumor Activity of Repeated ASP3026 Administration in Japanese Patients with Solid Tumors: A Phase I Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maiko Morishita Research Topics

Disease

2Neoplasms (Cancer)
03/2021 - 01/2020
1Cataract (Cataracts)
03/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020

Drug/Important Bio-Agent (IBA)

1ASP3026IBA
03/2021
1Anaplastic Lymphoma KinaseIBA
03/2021
1Alanine Transaminase (SGPT)IBA
03/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
03/2021
1Proteins (Proteins, Gene)FDA Link
03/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020
1SurvivinIBA
01/2020
1CytokinesIBA
01/2020
1sepantroniumIBA
01/2020